|Bid||0.00 x 800|
|Ask||30.25 x 800|
|Day's Range||27.47 - 29.85|
|52 Week Range||7.41 - 35.33|
|Beta (5Y Monthly)||2.14|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 04, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||35.81|
A look at the shareholders of Invitae Corporation (NYSE:NVTA) can tell us which group is most powerful. Generally...
Not all of the genetic tests it sells were particularly in demand as the COVID-19 pandemic intensified.
Ladies and gentlemen, thank you for standing by, and welcome to Invitae's second-quarter 2020 financial results conference call. Joining us today are Sean George, our CEO; Shelly Guyer, our CFO; Lee Bendekgey, our chief policy officer; Bob Nussbaum, our chief medical officer; and Katherine Stueland, our chief commercial officer.